The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Open accessAbstract
BACKGROUND: Recent studies have shown that an artificial-pancreas system can improve glucose control and reduce nocturnal hypoglycemia. However, it is not known whether such results can be replicated in settings outside the hospital. METHODS: In this multicenter, multinational, randomized, crossover trial, we assessed the short-term safety and efficacy of an artificial pancreas system for control of nocturnal glucose levels in patients (10 to 18 years of age) with type 1 diabetes at a diabetes camp. In two consecutive overnight sessions, we randomly assigned 56 patients to receive treatment with an artificial pancreas on the first night and a sensor-augmented insulin pump (control) on the second night or to the reverse order of therapies on the first and second nights. Thus, all the patients received each treatment in a randomly assigned order. The primary end points were the number of hypoglycemic events (defined as a sensor glucose value of <63 mg per deciliter [3.5 mmol per liter] for at least 10 consecutive minutes), the time spent with glucose levels below 60 mg per deciliter (3.3 mmol per liter), and the mean overnight glucose level for individual patients. RESULTS: On nights when the artificial pancreas was used, versus nights when the sensor-augmented insulin pump was used, there were significantly fewer episodes of nighttime glucose levels below 63 mg per deciliter (7 vs. 22) and significantly shorter periods when glucose levels were below 60 mg per deciliter (P=0.003 and P=0.02, respectively, after adjustment for multiplicity). Median values for the individual mean overnight glucose levels were 126.4 mg per deciliter (interquartile range, 115.7 to 139.1 [7.0 mmol per liter; interquartile range, 6.4 to 7.7]) with the artificial pancreas and 140.4 mg per deciliter (interquartile range, 105.7 to 167.4 [7.8 mmol per liter; interquartile range, 5.9 to 9.3]) with the sensor-augmented pump. No serious adverse events were reported. CONCLUSIONS: Patients at a diabetes camp who were treated with an artificial-pancreas system had less nocturnal hypoglycemia and tighter glucose control than when they were treated with a sensor-augmented insulin pump. (Funded by Sanofi and others; ClinicalTrials.gov number, NCT01238406.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 490
Self-citationHovorka, R., Allen, J. M., Elleri, D., Chassin, L. J., Harris, J., Xing, D., Kollman, C., Hovorka, T., Larsen, A. M. F., Nodale, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61998-x · Cited by 450
Evaluation of a New Measure of Blood Glucose Variability in Diabetes
Kovatchev, B. P., Otto, E., Cox, D., Gonder-Frederick, L., & Clarke, W. (2006) · Diabetes Care · doi:10.2337/dc06-1085 · Cited by 333
Use of Insulin Pump Therapy in the Pediatric Age-Group
Phillip, M., Battelino, T., Rodriguez, H., Danne, T., Kaufman, F., & participants, F. T. C. F. (2007) · Diabetes Care · doi:10.2337/dc07-9922 · Cited by 316
Self-citationEvaluating the Accuracy of Continuous Glucose-Monitoring Sensors
Kovatchev, B. P., Gonder-Frederick, L. A., Cox, D. J., & Clarke, W. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1922 · Cited by 312
Davis, E. A., Keating, B., Byrne, G. C., Russell, M., & Jones, T. W. (1997) · Diabetes Care · doi:10.2337/diacare.20.1.22 · Cited by 273
Insulin-pump therapy for type 1 diabetes mellitus
Pickup, J. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1113948 · Cited by 270
MD-Logic Artificial Pancreas System
Atlas, E., Nimri, R., Miller, S., Grunberg, E. A., & Phillip, M. (2010) · Diabetes Care · doi:10.2337/dc09-1830 · Cited by 266
Self-citationHovorka, R., Kumareswaran, K., Harris, J., Allen, J. M., Elleri, D., Xing, D., Kollman, C., Nodale, M., Murphy, H. R., Dunger, D. B., et al. (2011) · BMJ · doi:10.1136/bmj.d1855 · Cited by 244
Fear of hypoglycaemia in parents of young children with type 1 diabetes: A systematic review
Barnard, K., Thomas, S., Royle, P., Noyes, K., & Waugh, N. (2010) · BMC Pediatrics · doi:10.1186/1471-2431-10-50 · Cited by 239
Evaluating the Efficacy of Closed-Loop Glucose Regulation via Control-Variability Grid Analysis
Magni, L., Raimondo, D. M., Man, C. D., Breton, M., Patek, S., De Nicolao, G., Cobelli, C., & Kovatchev, B. P. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200414 · Cited by 207
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Kovatchev, B., Cobelli, C., Renard, E., Anderson, S., Breton, M., Patek, S., Clarke, W., Bruttomesso, D., Maran, A., Costa, S., et al. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400611 · Cited by 200
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-2081 · Cited by 180
Exercise in children and adolescents with diabetes
Robertson, K., Adolfsson, P., Scheiner, G., Hanas, R., & Riddell, M. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00567.x · Cited by 163
Monaghan, M. C., Hilliard, M. E., Cogen, F. R., & Streisand, R. M. (2009) · Families Systems & Health · doi:10.1037/a0014770 · Cited by 144
Use of continuous glucose monitoring in children and adolescents *
Phillip, M., Danne, T., Shalitin, S., Buckingham, B. A., Laffel, L. M., Tamborlane, W. V., Battelino, T., & Participants, F. T. C. F. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00849.x · Cited by 122
Self-citationAccuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms
Keenan, D. B., Mastrototaro, J. J., Zisser, H., Cooper, K. A., Gautham, R., Lee, S. W., Yusi, J., Bailey, T. S., Brazg, R., & Shah, R. V. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0199 · Cited by 103
Hughes, C. S., Patek, S. D., Breton, M. D., & Kovatchev, B. P. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400513 · Cited by 98
Dead-in-bed syndrome in young diabetic patients.
Søvik, O., & Thordarson, H. B. (1999) · PubMed · Cited by 97
Nimri, R., Atlas, E., Ajzensztejn, M., Miller, S., Oron, T., & Phillip, M. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0004 · Cited by 75
Self-citationA Novel Analytical Method for Assessing Glucose Variability: Using CGMS in Type 1 Diabetes Mellitus
McCall, A. L., Cox, D. J., Crean, J., Gloster, M., & Kovatchev, B. P. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.644 · Cited by 74
Hovorka, R., Nodale, M., Haidar, A., & Wilinska, M. E. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0185 · Cited by 61
Automated Overnight Closed-Loop Glucose Control in Young Children with Type 1 Diabetes
Elleri, D., Allen, J. M., Nodale, M., Wilinska, M. E., Mangat, J. S., Larsen, A. M. F., Acerini, C. L., Dunger, D. B., & Hovorka, R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0176 · Cited by 59
Automatic Learning Algorithm for the MD-Logic Artificial Pancreas System
Miller, S., Nimri, R., Atlas, E., Grunberg, E. A., & Phillip, M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0216 · Cited by 56
Self-citationParental Attitudes Towards Overnight Closed-Loop Glucose Control in Children with Type 1 Diabetes
Elleri, D., Acerini, C. L., Allen, J. M., Hayes, J., Pesterfield, C., Wilinska, M. E., Dunger, D. B., & Hovorka, R. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0084 · Cited by 51
Deiss, D., Hartmann, R., Hoeffe, J., & Kordonouri, O. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00053.x · Cited by 39
Self-citationInsulin dose changes in children attending a residential diabetes camp
Miller, A. R., Nebesio, T. D., & DiMeglio, L. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03220.x · Cited by 21
Safety and efficacy of blood glucose management practices at a diabetes camp
Gunasekera, H., & Ambler, G. R. (2006) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2006.00948.x · Cited by 20
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Chiang, J. L., Kirkman, M. S., Laffel, L. M. B., Peters, A. L., & Authors, O. B. O. T. T. 1. D. S. (2014) · Diabetes Care · doi:10.2337/dc14-1140 · Cited by 965
8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s008 · Cited by 699
DiMeglio, L. A., Acerini, C. L., Codner, E., Craig, M. E., Hofer, S. E., Pillay, K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12737 · Cited by 604
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Metadata
- Authors
- Phillip, M., Battelino, T., Atlas, E., Kordonouri, O., Bratina, N., Miller, S., Biester, T., Avbelj Stefanija, M., Muller, I., Nimri, R., & Danne, T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-02-28
- Volume
- 368
- Issue
- 9
- Pages
- 824-833
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2064863602
- Cited by
- 435
- References
- 33
- FWCI
- 51.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.